Dinutuximab Synergistically Enhances the Cytotoxicity of Natural Killer Cells to Retinoblastoma Through the Perforin-Granzyme B Pathway

PURPOSE: Conventional chemotherapy and enucleation usually fail to cure advanced retinoblastoma. We investigated the retinoblastoma immune microenvironment and the efficacy of the combination of dinutuximab and CD16-expressing NK-92MI (NK-92MI(hCD16-GFP)) cells on retinoblastoma cells in this study....

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Huixue, Yang, Jie, Pan, Hui, Tai, Mei Chee, Maher, Mohamed H, Jia, Renbing, Ge, Shengfang, Lu, Linna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218403/
https://www.ncbi.nlm.nih.gov/pubmed/32440155
http://dx.doi.org/10.2147/OTT.S228532

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218403/
https://www.ncbi.nlm.nih.gov/pubmed/32440155
http://dx.doi.org/10.2147/OTT.S228532

Ejemplares similares